STAT3 and inflammatory breast carcinoma: Intriguingly, a recent study of inflammatory breast cancer demonstrated a JAK2/STAT3 signaling axis that conferred chemoresistance and EMT, consistent with our findings of CAF2-regulated malignant cell traits [43].